Use of revised International Prognostic Scoring System (IPSS-R) in hypocellular myelodysplastic syndromes (MDS): Mayo Clinic experience. Pacritinib (PAC) vs best available therapy (BAT) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback